You are here

  • Home
  • Archive
  • Volume 2, Issue Suppl 3
  • Melanoma-derived Wnt5a conditions dendritic cells to promote regulatory T cell differentiation via the upregulation of indoleamine 2,3-dioxygenase: novel pharmacological strategies for augmenting immunotherapy efficacy

Article metrics

Article menu

Download PDFPDF

Poster Presentation
Melanoma-derived Wnt5a conditions dendritic cells to promote regulatory T cell differentiation via the upregulation of indoleamine 2,3-dioxygenase: novel pharmacological strategies for augmenting immunotherapy efficacy
Free

 

Online download statistics by month:

Online download statistics by month: January 2020 to June 2025

AbstractFullPdf
Jan 2020031
Feb 2020031
Mar 2020032
May 2020020
Jun 2020070
Jul 2020011
Aug 2020030
Sep 2020074
Oct 2020001
Nov 2020020
Dec 2020011
Jan 2021011
Feb 2021011
Mar 2021020
Apr 2021010
May 2021010
Jul 2021020
Aug 2021010
Sep 2021010
Oct 2021010
Nov 2021044
Dec 2021050
Jan 2022030
Feb 2022010
Mar 2022010
Apr 2022030
May 2022042
Jun 2022060
Jul 2022020
Aug 2022041
Sep 2022031
Oct 2022031
Nov 2022080
Dec 2022070
Jan 2023010
Feb 2023021
Jun 2023011
Jul 2023011
Aug 2023020
Sep 2023020
Oct 2023022
Nov 2023031
Dec 2023010
Jan 2024070
Feb 2024061
Mar 20240349
Apr 2024032
May 2024056
Jun 2024020
Jul 20240102
Aug 202408191
Sep 2024031
Oct 2024083
Nov 2024080
Dec 2024014
Jan 2025052
Feb 2025022
Mar 2025037
Apr 2025012
May 2025096
Jun 20250106
Total0206312